¶¶Òõ¶ÌÊÓƵ

Dr. Jan Vilcek describes the institutional support that helped make the widely-used drug Remicade happen.

Charles Marmar, MD, is advancing the study, diagnosis, and treatment of post-traumatic stress disorder.

Dr. Grossman shares insights with first-year medical students as part of NYU School of Medicine's Leaders & Teams lecture series.

The vice dean for science and chief scientific officer was honored for her contributions to cancer research.

Our chief clinical officer, Dr. Andrew Brotman, discusses a strategy for growth that puts patients first.

The 26-hour face transplant operation involved a team of more than 100 medical professionals.

Robert A. Montgomery, MD, DPhil, director of the Transplant Institute, discusses tissue rejection and making organ donations less invasive.

Dr. Preeti Raghavan helps pioneer techniques to restore arm and hand function in patients with neurological damage.

The director of the Perlmutter Cancer Center reflects on the challenges of building a leading cancer center.

A researcher uses ant colonies to study the molecular machinery that controls how genes express proteins.